Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Zhonghua Nan Ke Xue = National Journal of Andrology|October 14, 2014
[Impact of chronic diseases on erectile function]Jin-Cheng Tian, Rui Jiang
Zhonghua Nan Ke Xue = National Journal of Andrology|June 2, 2015
[Expressions of aquaporins decrease in the prostate and seminal vesicles of castrated rats]Jun Jiang, Jin-cheng Tian, Ji-yi Xia, et al.
International Journal of Surgery (London, England)|March 22, 2024
Neoadjuvant immunotherapy based on PD-1/L1 inhibitors for gastrointestinal tumors: a review of the rationale and clinical advancesDong-Xu Wang, Hui Liu, Jin-Cheng Tian, et al.
Molecular Cancer|January 15, 2024
Mutation status of the KMT2 family associated with immune checkpoint inhibitors (ICIs) therapy and implicating diverse tumor microenvironmentsDong-Xu Wang, Jun-Yu Long, Rui-Zhe Li, et al.
Clinical and Experimental Medicine|November 17, 2022
Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysisJin-Cheng Tian, Hui Liu, Lun-Jie Yan, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2023
Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patientsCheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, et al.
Clinical & Experimental Metastasis|June 12, 2023
Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysisBao-Wen Tian, Cheng-Long Han, Han-Chao Wang, et al.
JHEP Reports : Innovation in Hepatology|October 20, 2025
A pathomics-integrated multimodal model to evaluate chemoimmunotherapy efficacy in unresectable intrahepatic cholangiocarcinomaQi-Hang Cao, Han Li, Peng-Fei Sun, et al.
Pageof 1